Clinical Trial Update: International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 international trial evaluated inhaled alpha-1 antitrypsin in patients with emphysema due to alpha-1 antitrypsin deficiency; the study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emphysema

Drugs mentioned

• inhaled alpha-1 antitrypsin (alpha-1 antitrypsin)

Snippet

Sponsor: Kamada, Ltd. | Conditions: Emphysema | Phase 2, Phase 3 | Status: COMPLETED